News
The company's clinical chemistry test uses the NGAL biomarker to determine a patient's risk of acute kidney injury.
Proscia has integrated its Concentriq platform with AWS HealthImaging to provide a cloud-native foundation for pathology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback